In this episode of Patient Power’s podcast Unraveling Cancer, patient host Michele Nadeem-Baker speaks with Daniel Ermann, MD, Huntsman Cancer Institute, about how combination therapies are revolutionizing treatment for chronic lymphocytic leukemia. Dr. Ermann shares updates from recent clinical trials, the growing reality of chemo-free treatment, and promising developments such as bispecific antibodies and CAR T-cell therapy. The conversation gives patients insight into the rapidly advancing world of CLL care and what’s on the horizon.